In:
Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 144, No. Suppl_1 ( 2021-11-16)
Abstract:
Introduction: Severe aortic stenosis (AS) is often characterized by myocardial interstitial fibrosis (MIF). MIF, classically measured by magnetic resonance imaging, was shown to be accurately measured by computed tomography (CT)-derived extra cellular volume fraction (ECVF). Serum albumin level (SA, g/dL) has been shown to correlate with ECVF among patients with heart failure preserved ejection fraction. Aim: To evaluate the association between SA and ECVF among patients with severe symptomatic AS. Methods: Patients with symptomatic severe AS who were evaluated as candidates for intervention between 2016 and 2018, were enrolled prospectively. All patients underwent pre- and post-contrast CT for estimating myocardial ECVF. Valid ambulatory SA within 6 weeks of the cardiac CT were obtained and classified as (tertials): 〈 3.8, (3.8-4.19), ≥4.2 g/dL. Patients with acute systemic illness at the time of the albumin test were exclude. Results: The study included 68 patients, mean age 80.94±6.5, 53% females. Patients with lower SA were more likely to have chronic renal failure, prior percutaneous coronary interventions (PCI) and a reduced functional class. The mean ECVF (%) in the study cohort was 40.96±11.6%, significantly higher among the patients in the lower SA level groups (50±11.6% vs. 38.2±7.3% vs. 32.8±8.6% in the 〈 3.8 g/dL, 3.8-4.19 g/dL, ≥4.2 g/dL groups respectively, p for trend 〈 0.001). A statistically significant inverse correlation (figure 1) was found between SA levels and ECVF (r=-0.7, p 〈 0.001). Multivariable analysis showed significant independent association between low SA and ECVF. Conclusions: SA level is inversely associated with CT-derived ECVF in patients with severe AS. Additional studies are warranted to elucidate the pathophysiological mechanisms explaining the observed association and potential clinical implications
Type of Medium:
Online Resource
ISSN:
0009-7322
,
1524-4539
DOI:
10.1161/circ.144.suppl_1.10564
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2021
detail.hit.zdb_id:
1466401-X
Permalink